Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Southern California
mi
from
Los Angeles, CA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
UC Davis Comprehensive Cancer Center
mi
from
Sacramento, CA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
UC Davis Comprehensive Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Peoria Gynecologic Oncology
mi
from
Peoria, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Peoria Gynecologic Oncology
mi
from
Peoria, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Fox Chase Cancer Center
mi
from
Rockledge, PA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Fox Chase Cancer Center
mi
from
Rockledge, PA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Vancouver General Hospital
mi
from
Vancouver,
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Vancouver General Hospital
mi
from
Vancouver,
Click here to add this to my saved trials
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Status: Enrolling
Updated:  12/4/2015
Viriginia Commonwealth University, Department of Radiation Oncology
mi
from
Richmond, VA
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Status: Enrolling
Updated: 12/4/2015
Viriginia Commonwealth University, Department of Radiation Oncology
mi
from
Richmond, VA
Click here to add this to my saved trials
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study
Assessment of Changes in Pattern and Magnitude of Tumor FDG Uptake During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer
Status: Enrolling
Updated:  12/7/2015
Washington University in St. Louis
mi
from
Saint Louis, MO
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study
Assessment of Changes in Pattern and Magnitude of Tumor FDG Uptake During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer
Status: Enrolling
Updated: 12/7/2015
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
A Pilot Study of MR Imaging Based Intracavitary Brachytherapy for Cervical Cancer
Status: Enrolling
Updated:  12/14/2015
Abramson Cancer Center of the Unviersity of Pennsylvania
mi
from
Philadelphia, PA
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
A Pilot Study of MR Imaging Based Intracavitary Brachytherapy for Cervical Cancer
Status: Enrolling
Updated: 12/14/2015
Abramson Cancer Center of the Unviersity of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
Step up to Prevention : A Nurse Practitioner Guided Cervical Cancer Prevention Intervention
Status: Enrolling
Updated:  12/14/2015
Hospital of the University of Pennsylvania, Outpatient Ob/GYN clinic
mi
from
Philadelpahia, PA
Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
Step up to Prevention : A Nurse Practitioner Guided Cervical Cancer Prevention Intervention
Status: Enrolling
Updated: 12/14/2015
Hospital of the University of Pennsylvania, Outpatient Ob/GYN clinic
mi
from
Philadelpahia, PA
Click here to add this to my saved trials
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas
Status: Enrolling
Updated:  12/15/2015
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas
Status: Enrolling
Updated: 12/15/2015
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas
Status: Enrolling
Updated:  12/15/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
A Multicenter Phase II Study of Continuous Dosing of Sunitinib (Sutent®, SU11248) in Non-GIST Sarcomas
Status: Enrolling
Updated: 12/15/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
A Pilot Study of 18F-Flourodeoxyglucose Positron Emission Tomography in the Diagnosis of Primary and Recurrent Cervical Cancer
Status: Enrolling
Updated:  12/17/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
PET Scans in Diagnosing Primary or Recurrent Cervical Cancer in Patients Who Are Undergoing Surgery
A Pilot Study of 18F-Flourodeoxyglucose Positron Emission Tomography in the Diagnosis of Primary and Recurrent Cervical Cancer
Status: Enrolling
Updated: 12/17/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
A Pilot Study of Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Status: Enrolling
Updated:  12/21/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
A Pilot Study of Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Status: Enrolling
Updated: 12/21/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Status: Enrolling
Updated:  12/23/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Status: Enrolling
Updated: 12/23/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
RAD001 in Recurrent Endometrial Cancer Patients
A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer
Status: Enrolling
Updated:  1/6/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
RAD001 in Recurrent Endometrial Cancer Patients
A Phase II Study of RAD001 in Patients With Recurrent Endometrial Cancer
Status: Enrolling
Updated: 1/6/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Trisenox® in Women With Metastatic Endometrial Cancer
A Phase II Trial of Trisenox in Women With Recurrent or Metastatic Endometrial Adenocarcinoma
Status: Enrolling
Updated:  1/20/2016
North Carolina Cancer Hosptial, UNC
mi
from
Chapel Hill, NC
Trisenox® in Women With Metastatic Endometrial Cancer
A Phase II Trial of Trisenox in Women With Recurrent or Metastatic Endometrial Adenocarcinoma
Status: Enrolling
Updated: 1/20/2016
North Carolina Cancer Hosptial, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lymph Node Counts in Endometrial Cancer Staging
A Prospective Study of the Impact of Surgical and Pathologic Tissue Sampling Methods on Lymph Node Counts and Detection of Lymph Node Metastasis in Endometrial Cancer Staging
Status: Enrolling
Updated:  1/20/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Lymph Node Counts in Endometrial Cancer Staging
A Prospective Study of the Impact of Surgical and Pathologic Tissue Sampling Methods on Lymph Node Counts and Detection of Lymph Node Metastasis in Endometrial Cancer Staging
Status: Enrolling
Updated: 1/20/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Status: Enrolling
Updated:  1/22/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Status: Enrolling
Updated: 1/22/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
38 Week Extension Study to CAIN457C2303
A 38-week Extension to a 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet's Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy (SHIELD Study)
Status: Enrolling
Updated:  1/22/2016
Novartis
mi
from
Baltimore, MD
38 Week Extension Study to CAIN457C2303
A 38-week Extension to a 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet's Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy (SHIELD Study)
Status: Enrolling
Updated: 1/22/2016
Novartis
mi
from
Baltimore, MD
Click here to add this to my saved trials
38 Week Extension Study to CAIN457C2303
A 38-week Extension to a 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet's Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy (SHIELD Study)
Status: Enrolling
Updated:  1/22/2016
Novartis Investigative Site
mi
from
Alexandria,
38 Week Extension Study to CAIN457C2303
A 38-week Extension to a 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet's Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy (SHIELD Study)
Status: Enrolling
Updated: 1/22/2016
Novartis Investigative Site
mi
from
Alexandria,
Click here to add this to my saved trials
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
Status: Enrolling
Updated:  2/10/2016
North Shore LIJ Medical Center
mi
from
New Hyde Park, NY
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
Status: Enrolling
Updated: 2/10/2016
North Shore LIJ Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
Status: Enrolling
Updated:  2/10/2016
Albany Medical Center
mi
from
Albany, NY
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization Compared to Embosphere for Symptomatic Relief From Uterine Fibroids
Status: Enrolling
Updated: 2/10/2016
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Post Market Evaluation of Acessa With TAG
Post Market Evaluation of the Acessa System With Targeting Animation Guidance (TAG)
Status: Enrolling
Updated:  2/16/2016
Donald I Galen Consulting
mi
from
San Ramon, CA
Post Market Evaluation of Acessa With TAG
Post Market Evaluation of the Acessa System With Targeting Animation Guidance (TAG)
Status: Enrolling
Updated: 2/16/2016
Donald I Galen Consulting
mi
from
San Ramon, CA
Click here to add this to my saved trials
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer: Preferences of Women at High-Risk for Developing Cervix Cancer vs. Women Diagnosed With Cervix Cancer
Status: Enrolling
Updated:  2/25/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer
Simple Versus Radical Hysterectomy for Stage I Cervical Cancer: Preferences of Women at High-Risk for Developing Cervix Cancer vs. Women Diagnosed With Cervix Cancer
Status: Enrolling
Updated: 2/25/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Howard University Cancer Center
mi
from
Washington,
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Howard University Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Burlington County
mi
from
Mount Holly, NJ
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Burlington County
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Hematology Oncology Associates of Central New York, PC - Northeast Center
mi
from
East Syracuse, NY
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Hematology Oncology Associates of Central New York, PC - Northeast Center
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Don Monti Comprehensive Cancer Center at North Shore University Hospital
mi
from
Manhasset, NY
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Don Monti Comprehensive Cancer Center at North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Geisinger Cancer Institute at Geisinger Health
mi
from
Danville, PA
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Geisinger Cancer Institute at Geisinger Health
mi
from
Danville, PA
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
CCOP - Main Line Health
mi
from
Wynnewood, PA
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
CCOP - Main Line Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated:  3/1/2016
Nashville General Hospital at Meharry
mi
from
Nashville, TN
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Comparing the Lozenge to the Patch for Smoking Cessation
Status: Enrolling
Updated: 3/1/2016
Nashville General Hospital at Meharry
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Worcester, MA
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Slingerlands, NY
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Slingerlands, NY
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated:  3/7/2016
Investigator Site 102
mi
from
Brno,
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
Status: Enrolling
Updated: 3/7/2016
Investigator Site 102
mi
from
Brno,
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Tri-Cities Cancer Center
mi
from
Kennewick, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Tri-Cities Cancer Center
mi
from
Kennewick, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
SCCA at EvergreenHealth
mi
from
Kirkland, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
SCCA at EvergreenHealth
mi
from
Kirkland, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Skagit Valley Hospital
mi
from
Mount Vernon, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Skagit Valley Hospital
mi
from
Mount Vernon, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Olympic Medical Center
mi
from
Port Angeles, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Olympic Medical Center
mi
from
Port Angeles, WA
Click here to add this to my saved trials
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated:  3/8/2016
Group Health Cooperative
mi
from
Redmond, WA
Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children
Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Status: Enrolling
Updated: 3/8/2016
Group Health Cooperative
mi
from
Redmond, WA
Click here to add this to my saved trials